Serum miR-210 as a potential biomarker of early clear cell renal cell carcinoma
Serum miR-210 as a potential biomarker of early clear cell renal cell carcinoma is a paper indexed in ScholarIQ from OpenAlex.
How many citations does Serum miR-210 as a potential biomarker of early clear cell renal cell carcinoma have?
Serum miR-210 as a potential biomarker of early clear cell renal cell carcinoma has 115 citations in the OpenAlex counts ScholarIQ stores.
When was Serum miR-210 as a potential biomarker of early clear cell renal cell carcinoma published?
Serum miR-210 as a potential biomarker of early clear cell renal cell carcinoma has 2013 year in the ScholarIQ index.
What is the open-access status of Serum miR-210 as a potential biomarker of early clear cell renal cell carcinoma?
Serum miR-210 as a potential biomarker of early clear cell renal cell carcinoma has bronze oa status in the ScholarIQ index.
What is the DOI of Serum miR-210 as a potential biomarker of early clear cell renal cell carcinoma?
The DOI for Serum miR-210 as a potential biomarker of early clear cell renal cell carcinoma is on the source record.
What is the PMID of Serum miR-210 as a potential biomarker of early clear cell renal cell carcinoma?
The PMID for Serum miR-210 as a potential biomarker of early clear cell renal cell carcinoma is on the source record.
What is the OpenAlex record for Serum miR-210 as a potential biomarker of early clear cell renal cell carcinoma?
The OpenAlex for Serum miR-210 as a potential biomarker of early clear cell renal cell carcinoma is on the source record.